Works matching IS 11732563 AND DT 2018 AND VI 38 AND IP 5
Results: 11
Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick<sup>®</sup>): A Review in Asthma.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 463, doi. 10.1007/s40261-018-0644-2
- By:
- Publication type:
- Article
Retraction Note to: Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Retraction Note to: Combination Antiemetic Regimens for Prevention of Postoperative Nausea and Vomiting.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Differences in Metabolic Factors Between Antipsychotic-Induced Weight Gain and Non-pharmacological Obesity in Youths.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 457, doi. 10.1007/s40261-018-0627-3
- By:
- Publication type:
- Article
Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 449, doi. 10.1007/s40261-018-0626-4
- By:
- Publication type:
- Article
Sustained Virological Response in Special Populations with Chronic Hepatitis C Using Interferon-Free Treatments: A Systematic Review and Meta-analysis of Observational Cohort Studies.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 389, doi. 10.1007/s40261-018-0624-6
- By:
- Publication type:
- Article
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 475, doi. 10.1007/s40261-018-0623-7
- By:
- Publication type:
- Article
Cost Effectiveness of Daclatasvir Plus Asunaprevir Therapy for Chinese Patients with Chronic Hepatitis C Virus Genotype 1b.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 427, doi. 10.1007/s40261-018-0621-9
- By:
- Publication type:
- Article
Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 417, doi. 10.1007/s40261-018-0620-x
- By:
- Publication type:
- Article
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, SUVN-502, in Healthy Young Adults and Elderly Subjects.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 401, doi. 10.1007/s40261-018-0618-4
- By:
- Publication type:
- Article
Drug Interchangeability of Generic and Brand Products of Fixed Dose Combination Tablets of Sofosbuvir and Ledipasvir (400/90 mg): Employment of Reference Scaled Average Bioequivalence Study on Healthy Egyptian Volunteers.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 439, doi. 10.1007/s40261-018-0622-8
- By:
- Publication type:
- Article